Company intelligence

JOHNSON & JOHNSON (JNJ)

Quantfil combines the latest JNJ filing summary, key changes, financial snapshot, and recent trend context into one static page.

Healthcare 10-K Next earnings Date not scheduled

AI filing summary

JOHNSON & JOHNSON filing and earnings overview

The filing reads constructive based on revenue and statement momentum.

The latest 10-K for JNJ shows revenue was $94.2B and net income was $26.8B.

Key changes

What stands out in the latest report

  • Revenue moved to $94.2B from $88.8B (+6.0% vs prior).
  • Net income moved to $26.8B from $14.1B (+90.6% vs prior).
  • Diluted EPS moved to $11.03 from $5.79 (+90.5% vs prior).

Current read

Positive read

Financial snapshot

Latest reported figures

Revenue $94.2B
Net income $26.8B
EPS $11.03
Operating cash flow $24.5B

Trend section

Recent revenue trend

Q3 $22.5B

Period ended 2024-09-29

Q1 $21.9B

Period ended 2025-03-30

Q2 $23.7B

Period ended 2025-06-29

Q3 $24.0B

Period ended 2025-09-28

Trend section

Recent EPS trend

Q3 N/A

Filed period trend snapshot.

Q1 N/A

Filed period trend snapshot.

Q2 N/A

Filed period trend snapshot.

Q3 N/A

Filed period trend snapshot.

Related links

Move through the research workflow

Related companies

Read-throughs worth checking